# Catgut Embedding in Acupoints on Treating Persistent Atrial Fibrillation After Catheter Ablation

> **NCT05125042** · NA · UNKNOWN · sponsor: **Shanghai Chest Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **PROCEDURE:** Amiodarone hydrochloride tablet + acupoint catgut embedding
- **DRUG:** Amiodarone hydrochloride tablet

## Key facts

- **NCT ID:** NCT05125042
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-12-20
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2021-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05125042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05125042, "Catgut Embedding in Acupoints on Treating Persistent Atrial Fibrillation After Catheter Ablation". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05125042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*